两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$ONCONOVA THERAPEUTICS INC(ONTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-15 AccNo: 0001104659-17-032824 Size: 4 MB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2017-05-15 AccNo: 0001104659-17-032576 Size: 153 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 美东时间 2017-05-15 盘前 披露财报,预期EPS n/a 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-05-01 AccNo: 0001535610-17-000081 Size: 15 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2017-04-24 AccNo: 0001104659-17-025468 Size: 278 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-04-24 AccNo: 0001104659-17-025467 Size: 459 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2017-04-21 AccNo: 0001104659-17-024996 Size: 3 MB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-04-20 AccNo: 0001104659-17-024939 Size: 463 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2017-04-20 AccNo: 0001104659-17-024938 Size: 21 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-12 AccNo: 0001047469-17-002552 Size: 578 KB 网页链接